Drugs becoming eligible for first Paragraph IV ANDA filing in 2031
Drugs expiring in 2032
Drugs that contains Revefenacin
Drugs that contains Clobetasol Propionate
Idorsia patents expiration
Drugs that contains Darolutamide
Mytesi patents expiration
Drugs that contains Clobazam
